Here are three things to know:
1. Shai Yarkoni, MD, PhD, and Nuriel Chirich Kasbian co-founded the company in 2011.
2. Cellect recently received several patent grants for its Apograft technology, which is designed to replace costly and complex stem cell isolation methods.
3. Apograft-using devices are intended for bone marrow transplants, diabetes, inflammatory bowel disease, graft-versus-host-disease and more.
More articles on biologics:
Bio2 Technologies to begin enrolling patients in cervical interbody fusion device trial: 3 insights
3 things to know about Kuros Biosciences’ CEO
3 things to know about Histogenics
